Open in app
Sign inGet started
Go to the profile of Alex Zhavoronkov, PhD
Alex Zhavoronkov, PhD in InsilicoMedicine

Insilico to contribute to Oxford CDT research and educational program in AI

Read more…
Go to the profile of Alex Zhavoronkov, PhD
Alex Zhavoronkov, PhD in InsilicoMedicine

バック研究所(The Buck Institute)、インシリコ(Insilico) 医学、およびジュベネッセンス(Juvenescence)は老化関連疾患を阻害する治療薬を開発するためにナパセラピューティクスを設立する。 コラボレーションにより老化関連ターゲットを標的にしたAI技術を応用する。

Read more…
Go to the profile of Alex Zhavoronkov, PhD
Alex Zhavoronkov, PhD in InsilicoMedicine

Two longevity biotechnology companies partner to discover drugs that target aging

Read more…
Go to the profile of Alex Zhavoronkov, PhD
Alex Zhavoronkov, PhD in InsilicoMedicine

$100 million+ in “biobucks” for AI-powered drug discovery and longevity research: Q&A

Read more…
1 response
Go to the profile of Alex Zhavoronkov, PhD
Alex Zhavoronkov, PhD in InsilicoMedicine

I would like to congratulate our investors, friends, business partners, and fellow longevity biotechnology experts at Juvenescence on the first close of their series B. The company…

Read more…
Go to the profile of Alex Zhavoronkov, PhD
Alex Zhavoronkov, PhD in InsilicoMedicine

Insilico Medicine Secures $37M in Series B Funding Led by Qiming Venture Partners

Original press release by Qiming Venture Partners

Tuesday, September 10, Hong Kong — Insilico Medicine, a pioneer in next-generation artificial intelligence…

Read more…
Go to the profile of Alex Zhavoronkov, PhD
Alex Zhavoronkov, PhD in InsilicoMedicine

Molecular Sets (MOSES): a collaborative benchmarking platform for generative drug discovery

Read more…
1 response
Go to the profile of Alex Zhavoronkov, PhD
Alex Zhavoronkov, PhD in InsilicoMedicine

The new era for AI-powered drug discovery and longevity biotechnology begins for Insilico

Read more…
7 responses
Go to the profile of Alex Zhebrak
Alex Zhebrak in InsilicoMedicine

Insilico Medicine at ICML 2018 recap

Earlier this month our team attended the thirty-fifth annual International Conference on…

Read more…
Go to the profile of Alex Zhavoronkov, PhD
Alex Zhavoronkov, PhD in InsilicoMedicine

TARA Biosystems and Insilico Medicine announce collaboration for cardiac disease

Read more…
About
InsilicoMedicine
InsilicoMedicine
Insilico Medicine is an artificial intelligence company focusing on drug discovery, biomarker development, digital medicine and aging research. It is developing a full-stack engine and naturally plug-and-play into the "Big Pharma", "Big Tech" and consumer companies.
More information
Followers
393
Elsewhere